Preoperative transarterial XXXX using gelatin sponge for @entity2721 in the pelvis or extremities.

@entity1 @entity190 @entity5 @entity1416 @entity887 @entity2721 @entity158
BACKGROUND: Preoperative @entity1416 for @entity2721 plays an important role in reducing intraoperative @entity190 (IBL). PURPOSE: To evaluate the use of a gelatin sponge in preoperative @entity1416 for @entity2721 in the pelvis or extremities. MATERIAL AND METHODS: Thirty-seven @entity1 (21 @entity1 , 16 @entity1 ; median age, 61 years; age range, 23-79 years) underwent preoperative @entity1416 between April 2004 and January 2015. Medical records and images were reviewed, and the technical success rate, clinical success rate, and complications were evaluated. Technical success was defined as a devascularization rate of 75% or higher, and clinical success was defined as intraoperative @entity190 (IBL) <1500   mL in cases undergoing surgery within 3 days of transarterial @entity887 and <3000   mL in cases operated 4 or more days later. RESULTS: @entity5 sizes were in the range of 2.0-13.0   cm (median, 5.0   cm). The devascularization rate was decreased by >75% at follow-up angiography in all cases, and the technical success rate was 100 % (37/37). The median IBL was 491   mL (range, 30-3800   mL), and the clinical success rate was 89% (33/37). The minor complication of @entity158 was observed in 13 out of 37 cases (35%) during or after @entity887 , but was controllable by an analgesic. CONCLUSION: Preoperative transarterial @entity887 using a gelatin sponge appears to be feasible and safe, and may contribute to decreasing IBL.
